Article Details
Retrieved on: 2023-12-01 18:52:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibodies for the treatment of autoimmune diseases. The company's lead asset, IMVT-1402 is a next-generation antibody drug that has ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here